Lower plasma adiponectin concentrations in patients with essential hypertension are elevated when administrated with AngII type 1 receptor (AT1) blocker or angiotensin converting enzyme inhibitor (ACEI) [14]. The gene discussed is ADIPOQ; the disease is hypertensive disorder.